Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11794193 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Timing and Duration of Acute Hepatitis C Treatment
Condition: Hepatitis C
Interventions: Drug: Pegylated interferon alpha 2;   Drug: Ribavirin

Indicates status has not been verified in more than two years